Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300259
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,790
Award facts
- Contract value 50% obligated
-
- $6,789.60 Current, with exercised options
- $13,579.20 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61101, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, was awarded a Firm Fixed Price BPA (Blanket Purchase Agreement) call valued at $13,579.20 for drugs and biologicals on August 23, 2013. The contract, funded by a civilian federal agency under the Office of the Director, is set to be completed by February 28, 2014, with performance taking place in Rockford, Illinois. This award was issued without a set-aside designation and represents a task order placed against an existing blanket purchase agreement vehicle.
Thermo Electron Corporation, the parent entity, is an established supplier of scientific instruments and analytical equipment to federal agencies, including the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency. The company's subsidiary, Pierce Biotechnology, leverages this heritage to provide specialized products and services supporting federal research, regulatory, and public health initiatives. The relatively modest ceiling value of this particular call order suggests a targeted procurement for specific drugs or biologicals required to support ongoing federal operations or research activities.
Quick answers
Who was awarded contract HHSN26300259?
HHSN26300259 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on August 23, 2013.
How much is contract HHSN26300259 worth?
The government has obligated $6,790 on HHSN26300259. Its potential value, with all options, is $13,579.
Is contract HHSN26300259 an order under another contract?
Yes. HHSN26300259 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300259 competed?
The extent of competition for HHSN26300259 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award